Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for Chemotherapy-Induced Thrombocytopenia in Advanced Breast Cancer
NCT05394285Phase 2Completed
- Sponsor
- Henan Cancer Hospital
- Start
- Sep 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by Henan Cancer Hospital. Started Sep 2022; status: completed.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05394285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05394285.